Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery

New England Journal of Medicine

Volumn 363, Issue 17, 2010, Pages 1597-1607

  Leon, Martin B ^a   Smith, Craig R ^a   Mack, Michael ^b   Miller, D Craig ^c   Moses, Jeffrey W ^a   Svensson, Lars G ^e   Tuzcu, E Murat ^e   Webb, John G ^f   Fontana, Gregory P ^g   Makkar, Raj R ^g   Brown, David L ^b   Block, Peter C ^h   Guyton, Robert A ^h   Pichard, Augusto D ⁱ   Bavaria, Joseph E ^j   Herrmann, Howard C ^j   Douglas, Pamela S ^k   Petersen, John L ^k   Akin, Jodi J ^d   Anderson, William N ^d   Wang, Duolao ^l   Pocock, Stuart ^l   more..

^a NewYork Presbyterian Hospital   (United States)

^b Department of Clinical Research   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EDWARDS LIFESCIENCES   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WASHINGTON HOSPITAL CENTER   (United States)

^j HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE THERAPY; ECHOCARDIOGRAPHY; FEMALE; HAZARD RATIO; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; TREATMENT OUTCOME; VALVULOPLASTY; AORTIC VALVE STENOSIS; CATHETERIZATION; HEART CATHETERIZATION; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; CATHETERIZATION; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77958594295     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1008232     Document Type: Article

References (39)

1. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38:61-7.
2. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA, Bode RS Jr. Rate of progression of severity of valvular aortic stenosis in the adult. Am Heart J 1979;98:689-700.
3. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989;13:545-50.
4. Davies SW, Gershlick AH, Balcon R. Progression of valvular aortic stenosis: a long-term retrospective study. Eur Heart J 1991;12:10-4.
5. Peter M, Hoffmann A, Parker C, Lüscher T, Burckhardt D. Progression of aortic stenosis: role of age and concomitant coronary artery disease. Chest 1993;103: 1715-9.
6. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471-83. (Pubitemid 17093278)
7. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol 1988;61:123-30.
8. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1988 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118(15):e523-e661.
9. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10. (Pubitemid 12036848)
10. Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 1981;64: II-184-II-188.
11. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis: reasons for earlier operative intervention. Circulation 1990;82:124-39.
12. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery. Ann Thorac Surg 2009;88:Suppl:S23-S42.
13. Idem. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3 - valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88:Suppl: S43-S62.
14. Bouma BJ, van den Brink RBA, van der Meulen JHP, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999; 82:143-8.
15. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20.
16. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006;82:2111-5.
17. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement. Circ Cardiovasc Qual Outcomes 2009;2:533-9.
18. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.
19. Di Eusanio M, Fortuna D, De Palma R, et al. Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2010 July 2 (Epub ahead of print).
20. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
21. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703.
22. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: midterm follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
23. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50. (Pubitemid 43754305)
24. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the Core- Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease. Circulation 2006;114:1616-24. (Pubitemid 44547432)
25. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116:Suppl:I-240-I- 245.
26. Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86:46-55.
27. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Interv 2008;1:167-75.
28. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009;54:303-11.
29. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-16.
30. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
31. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55:1080-90.
32. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. Circulation 2010;122:62-9.
33. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
34. Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 2008;135: 732-8.
35. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75: 1856-64.
36. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002;166:111-7.
37. Finkelstein DM, Schoenfeld DA. Combining mortality and longitudinal measures in clinical trials. Stat Med 1999; 18:1341-54.
38. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010;121:870-8.
39. Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 2010;55:1427-32.